drugset / Trial / NCT06619678
A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)
NaSequentialOpen-labelTreatment
Summary
The main goals of this study are to learn what happens to Islatravir or MK-8507 in a person's body over time. Researchers will compare Islatravir given alone to Islatravir given with MK-8507. Researchers will also compare MK-8507 given alone to MK-8507 given with Islatravir.
Timeline
- Start
- 2024-01-17
- Primary completion
- 2024-06-23
- Completion
- 2024-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Islatravir | Other / unclassified | — | Oral |
| Subject | Ulonivirine | Small molecule | — | Oral |
Indications
No indication recorded.